Property that EQ has to lower estrogenic activity in a cycle
BOLDENONA -Property that EQ has to lower estrogenic activity in a cycle
Well, I am not an expert on steroid cycles like many here.
But I've been looking for knowledge on how to optimize a cycle efficiently without compromising E2 levels in the cycle!
Which led me to study more about the effect of EQ on reducing estrogen levels during the cycle.
I was interested in this when I saw a GearHeaded post telling other forum guys about it! ..
Well, before we start the discussion on the topic, I would like you all to read the text below, which reports :
Quote:
Text by Mike Arnold ...
Boldenone is said to aromatize at about 50% the testosterone rate, which should make it a very estrogenic drug, prone to causing estrogenic side effects such as gynecomastia and water retention, especially at higher doses. However, real-world experience has shown us that EQ is very unlikely to cause serious estrogenic side effects, even when given in high doses. For example, it is very common for a testosterone user to experience water retention and gynecomastia at a dose of 500 mg per week if left untreated ... and almost always occur when they venture in the range of 750 to 1,000 mg per week. Many users will find these side effects even when using 300 to 400 mg per week. However, when administering EQ at doses of 600-800 mg per week, these side effects rarely manifest ... and few users experience them even when using 1,000 mg per week or more! With EQ flavoring at half the testosterone rate, one would expect to see estrogenic side effects in a large percentage of users, but it does not. Why? One explanation is found in the metabolism of the drug. specifically, boldenone metabolizes to an anti-aromatase inhibitor known as 1,4 dienedone. This could certainly explain why boldenone, despite its relatively high aromatization rate, does not deliver even close to the estrogenic stroke that its aromatization rate entails. When administering EQ at doses of 600-800 mg per week, these side effects rarely manifest ... and few users experience them even when using 1,000 mg per week or more! With EQ flavoring at half the testosterone rate, one would expect to see estrogenic side effects in a large percentage of users, but it does not. Why? One explanation is found in the metabolism of the drug. Specifically, boldenone metabolizes to an anti-aromatase inhibitor known as 1,4 dienedone. This could certainly explain why boldenone, despite its relatively high aromatization rate, does not deliver even close to the estrogenic stroke that its aromatization rate entails.
Open discussion !!!